[Paraparesis as the main manifestation of brucellosis].
Gómez
M B
MB
Miravet
M J
MJ
Vilaplana
R
R
Marín
A J
AJ
Sánchez
J
J
Pérez
A
A
Piqueras
J
J
D000293:Adolescent; D000372:Agglutination Tests; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002006:Brucellosis / Q000134:cerebrospinal fluid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002555:Cerebrospinal Fluid / Q000166:cytology; D004172:Diplopia / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D008297:Male; D010264:Paraplegia / Q000209:etiology*; D011129:Polyradiculoneuropathy / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012395:Rose Bengal
D000900:Anti-Bacterial Agents; D012395:Rose Bengal; D011241:Prednisone; D012293:Rifampin
Paraparesia como principal manifestación de una brucelosis.